BioCatalyst

Ranibizumab, Port Delivery System with Ranibizumab — catalyst calendar

1 verified catalyst event(s) referencing Ranibizumab, Port Delivery System with Ranibizumab, each linked to its official source. Verified as of 2026-10-08.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-04
in 4mo
ESTIMATED
 READOUT
A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regime
Phase 3 · Neovascular Age-related Macular Degeneration (nAMD)
 Hoffmann-La Roche Ranibizumab, Port Delivery System with R ClinicalTrials.gov ↗
✓ Source-checked 2026-10-08
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.